enGene Ownership | Who Owns enGene?


OverviewForecastFinancialsChart

enGene Ownership Summary


enGene is owned by 80.31% institutional investors, 13.58% insiders, and 6.11% retail investors.

ENGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockenGene80.31%13.58%6.11%
SectorHealthcare Stocks 278.70%10.61%-189.31%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202531-8.82%40,941,351-0.88%801.22%9-59.09%814.29%
Dec 31, 20243413.33%41,304,52820.44%811.34%2237.50%775.00%
Sep 30, 202430-34,293,3915.17%771.42%1614.29%4-33.33%
Jun 30, 202430-3.23%32,608,6013.00%731.15%14-41.67%6100.00%
Mar 31, 202431181.82%31,657,538123.13%802.15%24118.18%3-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 30, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$5.00M
Oct 07, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$77.53K
Oct 04, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$39.24K
Oct 03, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$37.40K
Oct 08, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$5.28K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q47-
2024 Q34-

ENGN Ownership FAQ


Who Owns enGene?

enGene shareholders are primarily institutional investors at 80.31%, followed by 13.58% insiders and 6.11% retail investors. The average institutional ownership in enGene's industry, Biotech Stocks , is 63.84%, which enGene exceeds.

Does Blackrock own enGene?

BlackRock is not among the top 10 institutional shareholders of enGene.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools